Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Vertex Pharmaceutic (VRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 45,400,232
  • Shares Outstanding, K 255,560
  • Annual Sales, $ 2,489 M
  • Annual Income, $ 263,480 K
  • 36-Month Beta 1.48
  • Price/Sales 18.62
  • Price/Cash Flow 172.90
  • Price/Book 17.07

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 20 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 0.69
  • Number of Estimates 8
  • High Estimate 0.75
  • Low Estimate 0.64
  • Prior Year 0.24
  • Growth Rate Est. (year over year) +187.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
171.66 +6.44%
on 10/11/18
194.92 -6.26%
on 10/01/18
+3.70 (+2.07%)
since 09/14/18
3-Month
169.33 +7.90%
on 07/26/18
194.92 -6.26%
on 10/01/18
+1.49 (+0.82%)
since 07/16/18
52-Week
136.50 +33.85%
on 12/07/17
194.92 -6.26%
on 10/01/18
+28.01 (+18.11%)
since 10/16/17

Most Recent Stories

More News
J&J (JNJ) to Set the Ball Rolling for Pharma Q3 Earnings

The positive trend seen in J&J's (JNJ) pharma segment sales is likely to continue in the third quarter.

MRK : 70.64 (+1.70%)
JNJ : 136.14 (+1.63%)
VRTX : 183.27 (+3.16%)
AMGN : 200.52 (+2.52%)
CRISPR Therapeutics and Vertex Announce FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease

CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) today...

CRSP : 38.88 (+8.30%)
VRTX : 183.27 (+3.16%)
Why the Earnings Surprise Streak Could Continue for Vertex (VRTX)

Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

VRTX : 183.27 (+3.16%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 54.60 (+2.38%)
ILMN : 319.29 (+1.88%)
IBB : 113.32 (+2.93%)
VRTX : 183.27 (+3.16%)
AMGN : 200.52 (+2.52%)
XBI : 87.84 (+3.41%)
After Yesterday's Decline of 2.50%, Vertex Pharm Offers Investors Better Value

Vertex Pharm (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $187.10 to a high of $192.62. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $190.79...

VRTX : 183.27 (+3.16%)
Vertex Announces Access Contract in Denmark for Current and Future Cystic Fibrosis Medicines

--- Vertex also announces reimbursement in Austria for ORKAMBI(R) (lumacaftor/ivacaftor) to treat patients ages 6 through 11 with two copies of the F508del mutation -

VRTX : 183.27 (+3.16%)
3 Biotech Stocks With Rising Estimates in the Past Month

The biotech industry is performing reasonably well. Hence, it is a good idea to select stocks from the sector witnessing positive estimate revisions.

MESO : 7.37 (+2.36%)
TRVN : 0.95 (+11.76%)
CELG : 83.48 (+2.02%)
LGND : 212.12 (+6.02%)
VRTX : 183.27 (+3.16%)
GILD : 75.29 (+3.45%)
BIIB : 333.90 (+1.67%)
Guide to CRISPR Stocks & Latest Apple, Fed, GDP News | Free Lunch

Ryan McQueeney highlights the Fed's latest rate hike sentiment and new revisions to GDP growth estimates. He also recaps Bed Bath & Beyond's earnings results and touches on analyst research related to...

AAPL : 220.43 (+1.41%)
CRSP : 38.88 (+8.30%)
VRTX : 183.27 (+3.16%)
BBBY : 14.05 (+0.79%)
EDIT : 28.26 (+4.28%)
GILD : 75.29 (+3.45%)
NTLA : 23.72 (+6.13%)
Look for Shares of Vertex Pharm to Potentially Pullback after Yesterday's 2.86% Rise

Vertex Pharm (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $182.67 to a high of $188.10. Yesterday, the shares gained 2.9%, which took the trading range above the 3-day high of...

VRTX : 183.27 (+3.16%)
Vertex Pharm Falls 1.31% on Heavy Volume: Watch For Potential Rebound

Vertex Pharm (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $175.85 to a high of $179.59. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $177.09...

VRTX : 183.27 (+3.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade VRTX with:

Business Summary

Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs...

See More

Key Turning Points

2nd Resistance Point 182.15
1st Resistance Point 179.90
Last Price 183.27
1st Support Level 176.49
2nd Support Level 175.34

See More

52-Week High 194.92
Last Price 183.27
Fibonacci 61.8% 172.60
Fibonacci 50% 165.71
Fibonacci 38.2% 158.82
52-Week Low 136.50

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar